31. Cummings, DA, and Schut, HAJ: Inhibitory effect of dietary
4-ipomeanol on DNA adduct formation of the food mutagen
2-amino-3-methylimidazo[4,5-f ]quinoline in male CDF1 mice.
Carcinogenesis 16, 2523–2529, 1995.
32. Schut, HAJ, Wang, C-L, Twining, LM, and Earle, KM: Formation and
persistence of DNA adducts of 2-amino-3-methylimidazo[4,5-f ]quin-
oline (IQ) in CDF1 mice fed a high w-3 fatty acid diet. Mutat Res 378,
23–30, 1997.
33. Josyula, S, He, Y-H, Ruch, RJ, and Schut, HAJ: Inhibition of DNA
adduct formation of PhIP in female F344 rats by dietary conjugated
linoleic acid. Nutr Cancer 32, 132–138, 1998.
34. Schut, HAJ, and Herzog, CR: Formation of DNA adducts of
2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in male
Fischer-344 rats. Cancer Lett 67, 117–124, 1992.
47. Hirose, M, Akagi, K, Hasegawa, R, Yaono, M, Satoh, T, et al.:
Chemoprevention of 2-amino-1-methyl-6-phenylimidazo[4,5-
b]pyridine (PhIP)-induced mammary gland carcinogenesis by antioxi-
dants in F344 female rats. Carcinogenesis 16, 217–221, 1995.
48. Weisburger, JH, Rivenson, A, Garr, K, and Aliaga, C: Tea, or tea and
milk, inhibit mammary gland and colon carcinogenesis in rats. Cancer
Lett 114, 323–327, 1997.
49. Rogers, AE, Hafer, LJ, Iskander, YS, and Yang, S: Black tea and mam-
mary carcinogenesis by 7,12-dimethylbenz[a]anthracene in rats fed
control or high fat diets. Carcinogenesis 19, 1269–1273, 1998.
50. Narisawa, T, and Fukaura, Y: A very low dose of green tea poly-
phenols in drinking water prevents N-methyl-N-nitrosourea-induced
colon carcinogenesis in F344 rats. Jpn J Cancer Res 84, 1007–1009,
1993.
35. Cummings, DA, and Schut, HAJ: Removal of DNA adducts of
2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the male
Fischer-344 rat. Carcinogenesis 15, 2623–2628, 1994.
36. He, Y-H, Friesen, MD, Ruch, RJ, and Schut, HAJ: Indole-3-carbinol as
a chemopreventive agent in PhIP carcinogenesis: inhibition of
PhIP-DNA adduct formation, acceleration of PhIP metabolism and in-
duction of cytochrome P450 in female F344 rats. Food Chem Toxicol
38, 15–23, 2000.
37. Friesen, MD, Cummings, DA, Garren, L, Butler, R, Bartsch, H, et al.:
Validation in rats of two biomarkers of exposure to the food-borne car-
cinogen: 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP):
PhIP-DNA adducts and urinary PhIP. Carcinogenesis 17, 67–72, 1996.
38. Takahashi, S, Tamano, S, Hirose, M, Kimoto, N, Ikeda, Y, et al.:
Immunohistochemical demonstration of carcinogen-DNA adducts in
tissues of rats given 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyri-
dine (PhIP): detection in paraffin-embedded sections and tissue distri-
bution. Cancer Res 58, 4307–4313, 1998.
39. Schut, HAJ, Cummings, DA, Smale, MHE, Josyula, S, and Friesen,
MD: DNA adducts of heterocyclic amines: formation, removal and in-
hibition by dietary components. Mutat Res 376, 187–194, 1997.
40. Schut, HAJ: Effects of dietary menhaden oil on DNA adducts of the
food mutagen 2-amino-3-methylimidazo[4,5-f ]quinoline (IQ) in
Fischer-344 rats. Anticancer Res 13, 1517–1524, 1993.
41. Josyula, S, and Schut, HAJ: Dietary w-3 fatty acids as potential inhibi-
tors of carcinogenesis: effect on DNA adduct formation of 2-amino-1-
methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in mice and rats. Food
Chem Toxicol 37, 287–296, 1999.
42. Guo, D, Schut, HAJ, Davis, CD, Snyderwine, EG, Bailey, GS, et al.:
Protection by chlorophyllin and indole-3-carbinol against 2-amino-1-
methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced DNA adducts
and colonic aberrant crypts in the F344 rat. Carcinogenesis 16, 2931–
2937, 1995.
43. He, Y-H, and Schut, HAJ: Inhibition of DNA adduct formation of
2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and 2-ami-
no-3-methylimidazo[4,5-f ]quinoline (IQ) by dietary indole-3-carbinol
in female rats. J Biochem Mol Toxicol, 13, 239–247, 1999.
44. Kaderlik, KR, Minchin, RF, Mulder, GJ, Ilett, KF, Daugaard-Jenson,
M, et al.: Metabolic activation pathway for the formation of DNA ad-
ducts of the carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]py-
ridine (PhIP) in rat extrahepatic tissues. Carcinogenesis 15, 1703–
1709, 1994.
45. Ghoshal, A, Davis, CD, Schut, HAJ, and Snyderwine, EG: Possible
mechanisms for PhIP-DNA adduct formation in the mammary gland of
female Sprague-Dawley rats. Carcinogenesis 16, 2725–2731, 1995.
46. Hirose, M, Hoshiya, T, Akagi, K, Futakuchi, M, and Ito, N: Inhibition
of mammary gland carcinogenesis by green tea catechins and other
naturally occurring antioxidants in female Sprague-Dawley rats
pretreated with 7,12-dimethylbenz[a]anthracene. Cancer Lett 83, 149–
156, 1994.
51. Yin, P, Zhao, J, Cheng, S, Hara, Y, Zhu, Q, et al.: Experimental studies
of the inhibitory effects of green tea catechin on mice large intestinal
cancers induced by 1,2-dimethylhydrazine. Cancer Lett 79, 33–38,
1994.
52. Yamane, T, Hagiwara, N, Tateishi, M, Akachi, S, Kim, M, et al.: Inhi-
bition of azoxymethane-induced colon carcinogenesis in rat by green
tea polyphenol fraction. Jpn J Cancer Res 82, 1336–1339, 1991.
53. Hirose, M, Hoshiya, T, Akagi, K, Takahashi, S, Hara, Y, et al.: Effects
of green tea catechins in a rat multi-organ carcinogenesis model.
Carcinogenesis 14, 1549–1553, 1993.
54. Malfatti, MA, Connors, MS, Mauthe, RJ, and Felton, JS: The capabil-
ity of rat colon tissue slices to metabolize the cooked-food carcinogen
2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Cancer Res 56,
2550–2555, 1996.
55. Hirose, M, Hasegawa, R, Kimura, J, Akagi, K, Yoshida, Y, et al.: In-
hibitory effects of 1-O-hexyl-2,3,5-trimethylhydroquinone (HTHQ),
green tea catechins and other antioxidants on 2-amino-6-methyl-
dipyrido[l,2-a:3',2'-d]imidazole (Glu-P-1)-induced rat hepato-
carcinogenesis and dose-dependent inhibition by HTHQ of lesion
induction by Glu-P-1 or 2-amino-3,8-dimethylimidazo[4,5-f]quinoxa-
line (MeIQx). Carcinogenesis 16, 3049–3055, 1995.
56. Hirose, M, Futakuchi, M, Tanaka, H, Orita, S-I, Ito, T, et al.: Preven-
tion by antioxidants of heterocyclic amine-induced carcinogenesis in a
rat medium-term liver bioassay: results of extended and combination
treatment experiments. Eur J Cancer Prev 7, 61–67, 1998.
57. Ito, N, Hasegawa, R, Imaida, K, Hirose, M, Shirai, T, et al.: Me-
dium-term rat liver bioassay for rapid detection of hepatocarcinogenic
substances. Toxicol Pathol 10, 1–11, 1997.
58. Moore, MA, Tsuda, H, Tamano, S, Hagiwara, A, Imaida, K, et al.:
Marriage of a medium-term liver model to surrogate markers—a prac-
tical approach for risk and benefit assessment. Toxicol Pathol 27,
237–242, 1999.
59. Hammons, GJ, Fletcher, JV, Stepps, KR, Smith, EA, Balentine, DA, et
al.: Effects of chemoprotective agents on the metabolic activation of
the carcinogenic arylamines PhIP and 4-aminobiphenyl in human and
rat liver microsomes. Nutr Cancer 33, 46–52, 1999.
60. Chen, L, Bondoc, FY, Lee, M-J, Hussin, AH, Thomas, PE, et al.: Caf-
feine induces cytochrome P4501A2: induction of CYP1A2 by tea in
rats. Drug Metab Dispos 24, 529–533, 1996.
61. Tsuda, H, Uehara, N, Iwahori, Y, Asamoto, M, Iigo, M, et al.:
Chemopreventive effects of b-carotene, a-tocopherol and five natu-
rally occurring antioxidants on initiation of hepatocarcinogenesis by
2-amino-3-methylimidazo[4,5-f ]quinoline in the rat. Jpn J Cancer Res
85, 1214–1219, 1994.
62. Hasaniya, N, Youn, K, Xu, M, Hernaez, J, and Dashwood, R: Inhibi-
tory activity of green and black tea in a free radical generating system
using 2-amino-3-methylimidazo[4,5-f ]quinoline as substrate. Jpn J
Cancer Res 88, 553–558, 1997.
58
Nutrition and Cancer 2000